Symbiomix Therapeutics is Drug Discovery in United States that focus on developer business. Founded in 2012. They cover business area such as developer, antibiotic drug, innovative medicine, gynecologic infection, enhanced pharmacokinetic property, efficacious and well tolerate delivery, a single dose, patient, bacterial vaginosis.
2012
( 12 years old in 2024 )
Developer
-
105 Lock Street
Suite 409
Newark, NJ 07103
United States
Private
developerantibiotic druginnovative medicinegynecologic infectionenhanced pharmacokinetic propertyefficacious and well tolerate deliverya single dosepatientbacterial vaginosis
* We use standard office opening hours in near Symbiomix Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Symbiomix Therapeutics is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Symbiomix Therapeutics business is focusing on Developer.
Symbiomix Therapeutics headquarter office and corporate office address is located in 105 Lock Street Suite 409 Newark, NJ 07103 United States.
Symbiomix Therapeutics was founded in United States.
In 2024, Symbiomix Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Symbiomix Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
